BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35816852)

  • 1. Prognostic values of preoperative C-reactive protein, albumin, and neutrophil ratios in patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy.
    Okita R; Okada M; Inokawa H; Murakami T; Ikeda E
    Surg Oncol; 2022 Aug; 43():101813. PubMed ID: 35816852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
    Kao SC; Klebe S; Henderson DW; Reid G; Chatfield M; Armstrong NJ; Yan TD; Vardy J; Clarke S; van Zandwijk N; McCaughan B
    J Thorac Oncol; 2011 Nov; 6(11):1923-9. PubMed ID: 22011651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical strategy for malignant pleural mesothelioma: the superiority of pleurectomy/decortication.
    Kanayama M; Mori M; Matsumiya H; Taira A; Shinohara S; Takenaka M; Kuroda K; Tanaka F
    Surg Today; 2022 Jul; 52(7):1031-1038. PubMed ID: 35044520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
    Ann Thorac Cardiovasc Surg; 2018 Apr; 24(2):81-88. PubMed ID: 29367501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients.
    Sugarbaker DJ; Richards WG; Bueno R
    Ann Surg; 2014 Oct; 260(4):577-80; discussion 580-2. PubMed ID: 25203873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of prognostic factors and patient selection for extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma.
    Cao C; Yan TD; Bannon PG; McCaughan BC
    Ann Surg Oncol; 2011 Oct; 18(10):2973-9. PubMed ID: 21512863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections.
    Bölükbas S; Eberlein M; Fisseler-Eckhoff A; Schirren J
    Lung Cancer; 2013 Aug; 81(2):241-6. PubMed ID: 23688589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.
    Infante M; Morenghi E; Bottoni E; Zucali P; Rahal D; Morlacchi A; Ascolese AM; De Rose F; Navarria P; Crepaldi A; Testori A; Voulaz E; Errico V; Perrino M; Scorsetti M; Chiti A; Santoro A; Alloisio M
    Eur J Cardiothorac Surg; 2016 Dec; 50(6):1077-1082. PubMed ID: 27330149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions.
    Lauk O; Hoda MA; de Perrot M; Friess M; Klikovits T; Klepetko W; Keshavjee S; Weder W; Opitz I
    Ann Thorac Surg; 2014 Nov; 98(5):1748-54. PubMed ID: 25110339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapleural pneumonectomies for pleural mesothelioma.
    Faccioli E; Bellini A; Mammana M; Monaci N; Schiavon M; Rea F
    Expert Rev Respir Med; 2020 Jan; 14(1):67-79. PubMed ID: 31674841
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma.
    Yeap BY; De Rienzo A; Gill RR; Oster ME; Dao MN; Dao NT; Levy RD; Vermilya K; Gustafson CE; Ovsak G; Richards WG; Bueno R
    J Thorac Oncol; 2021 Nov; 16(11):1925-1935. PubMed ID: 34242791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of long-term survival following radical surgery for malignant pleural mesothelioma.
    Nakas A; Waller D
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):380-5; discussion 385. PubMed ID: 24482386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis.
    Okita R; Kawamoto N; Okada M; Inokawa H; Yamamoto N; Murakami T; Ikeda E
    Sci Rep; 2023 Mar; 13(1):5263. PubMed ID: 37002247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.
    Takuwa T; Hashimoto M; Matsumoto S; Kondo N; Kuribayash K; Nakano T; Hasegawa S
    Int J Clin Oncol; 2017 Oct; 22(5):857-864. PubMed ID: 28439676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.
    Linton A; Pavlakis N; O'Connell R; Soeberg M; Kao S; Clarke S; Vardy J; van Zandwijk N
    Br J Cancer; 2014 Oct; 111(9):1860-9. PubMed ID: 25188323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extrapleural pneumonectomy for malignant pleural mesothelioma].
    Hosokawa Y; Matsuge S; Hayashi K; Kawahara Y; Ishigooka M; Kan T; Yamaawa T; Hatakeyama H; Murakami Y
    Kyobu Geka; 2004 Oct; 57(11):1018-22. PubMed ID: 15510814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy.
    Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Yildizeli B; Yuksel M
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):478-84. PubMed ID: 26611742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Conversion to Extrapleural Pneumonectomy From Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
    Nakamura A; Hashimoto M; Matsumoto S; Kondo N; Kijima T; Hasegawa S
    Semin Thorac Cardiovasc Surg; 2021; 33(3):873-881. PubMed ID: 33609685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.
    Bovolato P; Casadio C; Billè A; Ardissone F; Santambrogio L; Ratto GB; Garofalo G; Bedini AV; Garassino M; Porcu L; Torri V; Pastorino U
    J Thorac Oncol; 2014 Mar; 9(3):390-6. PubMed ID: 24518090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy.
    Arrossi AV; Lin E; Rice D; Moran CA
    Am J Clin Pathol; 2008 Nov; 130(5):754-64. PubMed ID: 18854268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.